The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.
暂无分享,去创建一个
Patrick R. Cushing | D. Madden | P. Boisguérin | Dean R Madden | Abigail Fellows | Abigail Fellows | Daniela Villone | Patrick R Cushing | Daniel Villone | Prisca Boisguérin
[1] B. Papsin,et al. Misfolding diverts CFTR from recycling to degradation , 2004, The Journal of cell biology.
[2] A. Piserchio,et al. The PDZ1 Domain of SAP90 , 2002, The Journal of Biological Chemistry.
[3] J. Riordan,et al. The PDZ-binding Chloride Channel ClC-3B Localizes to the Golgi and Associates with Cystic Fibrosis Transmembrane Conductance Regulator-interacting PDZ Proteins* , 2003, The Journal of Biological Chemistry.
[4] P. Schatz,et al. Peptide binding consensus of the NHE‐RF‐PDZ1 domain matches the C‐terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR) , 1998, FEBS letters.
[5] Sudhir C. Sharma,et al. Design, synthesis, and evaluation of linear and cyclic peptide ligands for PDZ10 of the multi-PDZ domain protein MUPP1. , 2007, Biochemistry.
[6] S Grinstein,et al. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. , 1993, The Journal of biological chemistry.
[7] N. Heintz,et al. A Novel Protein Complex Linking the δ2 Glutamate Receptor and Autophagy Implications for Neurodegeneration in Lurcher Mice , 2002, Neuron.
[8] G. Cutting,et al. PDZ Domain Interaction Controls the Endocytic Recycling of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2002, The Journal of Biological Chemistry.
[9] A. Bretscher,et al. An Apical PDZ Protein Anchors the Cystic Fibrosis Transmembrane Conductance Regulator to the Cytoskeleton* , 1998, The Journal of Biological Chemistry.
[10] W. Stafford,et al. Analysis of heterologous interacting systems by sedimentation velocity: curve fitting algorithms for estimation of sedimentation coefficients, equilibrium and kinetic constants. , 2004, Biophysical chemistry.
[11] T. Leung,et al. Structural Basis of the Na+/H+ Exchanger Regulatory Factor PDZ1 Interaction with the Carboxyl-terminal Region of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2001, The Journal of Biological Chemistry.
[12] Min Goo Lee,et al. Dynamic Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Competitive Interactions of Molecular Adaptors* , 2007, Journal of Biological Chemistry.
[13] A. Beaudet,et al. Interactions with PDZ Domain Proteins PIST/GOPC and PDZK1 Regulate Intracellular Sorting of the Somatostatin Receptor Subtype 5* , 2005, Journal of Biological Chemistry.
[14] Gavin MacBeath,et al. Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays. , 2006, Journal of the American Chemical Society.
[15] T. Flotte,et al. The Short Apical Membrane Half-life of Rescued ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of ΔF508-CFTR in Polarized Human Airway Epithelial Cells* , 2005, Journal of Biological Chemistry.
[16] Prisca Boisguerin,et al. An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. , 2004, Chemistry & biology.
[17] L. Cantley,et al. Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.
[18] Jiunn R Chen,et al. PDZ Domain Binding Selectivity Is Optimized Across the Mouse Proteome , 2007, Science.
[19] V. Rybin,et al. Computer-aided design of a PDZ domain to recognize new target sequences , 2002, Nature Structural Biology.
[20] Prisca Boisguerin,et al. Characterization of a Putative Phosphorylation Switch: Adaptation of SPOT Synthesis to Analyze PDZ Domain Regulation Mechanisms , 2007, Chembiochem : a European journal of chemical biology.
[21] Aleksandr Kivenson,et al. Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. , 2007, The Journal of biological chemistry.
[22] R. Boucher. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. , 2007, Annual review of medicine.
[23] A. Bretscher,et al. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor , 1999, Nature.
[24] D. Xie,et al. Molecular basis of cooperativity in protein folding. V. Thermodynamic and structural conditions for the stabilization of compact denatured states , 1994, Proteins.
[25] Seth G. N. Grant,et al. PDZ Domain Proteins: Plug and Play! , 2003, Science's STKE.
[26] G. Cutting,et al. A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane. , 2001, Journal of cell science.
[27] P. Schuck,et al. Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. , 2004, Methods in enzymology.
[28] J M Sturtevant,et al. Thermodynamics of the binding of L-arabinose and of D-galactose to the L-arabinose-binding protein of Escherichia coli. , 1983, The Journal of biological chemistry.
[29] M. Welsh,et al. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Marshall,et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.
[31] Nicole Caspers,et al. A thermodynamic ligand binding study of the third PDZ domain (PDZ3) from the mammalian neuronal protein PSD-95. , 2007, Biochemistry.
[32] R. Marchase,et al. Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Ladbury,et al. Isothermal titration calorimetry of biomolecules , 1998 .
[34] Matthew P. Anderson,et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.
[35] G. Cutting,et al. A Golgi-associated PDZ Domain Protein Modulates Cystic Fibrosis Transmembrane Regulator Plasma Membrane Expression* , 2002, The Journal of Biological Chemistry.
[36] Andrea Piserchio,et al. Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. , 2004, Chemistry & biology.
[37] M. Conese,et al. Na+/H+ Exchanger Regulatory Factor Isoform 1 Overexpression Modulates Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Activity in Human Airway 16HBE14o- Cells and Rescues ΔF508 CFTR Functional Expression in Cystic Fibrosis Cells* , 2005, Journal of Biological Chemistry.
[38] P. Schuck,et al. Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. , 1997, Current opinion in biotechnology.
[39] J. Schlessinger,et al. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Larusch,et al. PDZ‐binding motifs are unable to ensure correct polarized protein distribution in the absence of additional localization signals , 2005, FEBS letters.
[41] D. Mak,et al. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] N. Bradbury,et al. E3KARP Mediates the Association of Ezrin and Protein Kinase A with the Cystic Fibrosis Transmembrane Conductance Regulator in Airway Cells* , 2000, The Journal of Biological Chemistry.
[43] J. Hell,et al. Selectivity and Promiscuity of the First and Second PDZ Domains of PSD-95 and Synapse-associated Protein 102* , 2002, The Journal of Biological Chemistry.
[44] Jian-guo Li,et al. Ezrin-Radixin-Moesin-binding Phosphoprotein-50/Na+/H+ Exchanger Regulatory Factor (EBP50/NHERF) Blocks U50,488H-induced Down-regulation of the Human κ Opioid Receptor by Enhancing Its Recycling Rate* , 2002, The Journal of Biological Chemistry.
[45] Z. X. Wang,et al. An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule , 1995, FEBS letters.
[46] Andrea Piserchio,et al. Association of the cystic fibrosis transmembrane regulator with CAL: structural features and molecular dynamics. , 2005, Biochemistry.
[47] F. Collins,et al. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.
[48] G. Roomans. Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic Fibrosis , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.
[49] Junqi He,et al. Interaction with Cystic Fibrosis Transmembrane Conductance Regulator-associated Ligand (CAL) Inhibits β1-Adrenergic Receptor Surface Expression* , 2004, Journal of Biological Chemistry.
[50] Pascal Barbry,et al. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation , 1991, Nature.
[51] G. Joberty,et al. PIST: a novel PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10. , 2001, Biochemical and biophysical research communications.
[52] W. Guggino,et al. Modulation of Mature Cystic Fibrosis Transmembrane Regulator Protein by the PDZ Domain Protein CAL* , 2004, Journal of Biological Chemistry.
[53] A. Naren,et al. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. , 2005, Pharmacology & therapeutics.
[54] D. Callaway,et al. Ezrin Controls the Macromolecular Complexes Formed between an Adapter Protein Na+/H+ Exchanger Regulatory Factor and the Cystic Fibrosis Transmembrane Conductance Regulator* , 2005, Journal of Biological Chemistry.